Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0633 in Chronic Asthma
NCT00404313Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jan 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of setileuton in asthma, sponsored by Merck & Co.. Started Jan 2008; status: terminated.
02
Drugs
setileuton
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00404313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404313.